ACTIVE SESSION TAPE Biotechnology $204M Cap Quant: HOLD

Why Is Sangamo Therapeutics, Inc. (SGMO) Stock Up Today?

Updated Nov 16, 2026 2:36 PM ET · Prev Close $0.14

Pro Workspace
Last Session Price
$0.18 +31.56%
+$0.04 vs $0.14 prior close
Intraday Range
$0.13 – $0.22
Open $0.13
Relative Volume
6.50x Avg
93,790,833 sh
52-Week Range
$0.12 – $0.78
Benchmark Alpha
+33.45% vs SPY
+33.98% vs QQQ
20-Session Trend -30.7%

Session Regime & Catalyst Assessment

68% Signal Conviction
TECHNICAL 68% Driver Weight

Sangamo Therapeutics, Inc. Advancing 31.56% on 6.50x Relative Volume

Sangamo Therapeutics, Inc. (SGMO) is advancing 31.56% (+$0.04) to $0.18 on 6.50x average session volume. Relative to benchmarks, SGMO is outperforming the S&P 500 by +33.45%. 14-day RSI stands at 38.4, keeping momentum in a bearish regime.

NEWS 70% Weight
Sangamo Therapeutics Launches Auction Process for Clinical-Stage Chronic Neuropathic Pain Program

Auction process initiated for ST-503 program for chronic neuropathic pain, expected to be completed in fourth quarter of 2026 Previously announced asset sale transactions with PTC and Lilly have closed, generating 163.55

TECHNICAL 68% Weight
Moving Average Structure: Bearish Alignment

Price ($0.18) trades relative to 20-day SMA ($0.23) and 50-day SMA ($0.31).

Volume Confirmation
HIGH VOLUME (6.50x) Accumulation
Institutional participation confirms directional price action.
Composite Catalyst Confidence 68%
Cross-checked across volume tape, benchmark alpha, options flow, and news.

Market & Sector Relative Strength

SGMO outperforming the S&P 500 by +33.45%
SGMO Session
+31.56%
$0.18
S&P 500 (SPY)
-1.89%
$740.11
Nasdaq 100 (QQQ)
-2.42%
$663.44
Healthcare (XLV)
-0.38%
$188.14
Alpha vs SPY: +33.45% Alpha vs QQQ: +33.98% Alpha vs XLV: +31.94%

Options Flow & Execution Desk

Recent SGMO Catalyst Headlines

Verified Wire

1–3 Day Expected Range & Key Level

54% Follow-Through
Lower Bound
$0.17
Short-term support band
Upper Bound
$0.19
Short-term resistance band
Key Inflection Level
$0.22 (session resistance)

Monitor volume expansion above 1.5x RVOL around $0.22 (session resistance) for directional breakout confirmation.

Technical Regime (SGMO)

BEARISH MA TREND
RSI (14)
38.4
Bearish
20-Day SMA
$0.23
Below 20d
50-Day SMA
$0.31
Below 50d
MACD Signal
Bearish
MACD -0.04
ADX (14)
26.9
Strong trend
10d Momentum
-0.09
Soft 10-day momentum

Retail & Crowd Sentiment

Bullish
24h Messages
0
7d avg 0.0
Bullish / Bearish
0.0% / 0.0%
None buzz
Crowd Discussion Digest

Bullish sentiment dominates $SGMO on StockTwits with traders expressing optimism about the stock's performance and potential partnerships with companies like Palantir Technologies ($PLTR). No recent news articles were available.

Reddit communities: 1 comment (Bullish)

About Sangamo Therapeutics, Inc.

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, Als/Ftd, and Huntington's Disease; and …

Sector
Healthcare
Market Cap
$204M
Employees
183

Get Instant SGMO Catalyst Alerts

Receive an email alert when SGMO triggers an unusual volume breakout, options sweep, or rating shift.

Other Liquid Stocks Moving Today

All Today's Movers

SGMO Session & Catalyst FAQ

Why is SGMO stock up today?

Sangamo Therapeutics, Inc. (SGMO) is advancing 31.56% (+$0.04) to $0.18 on 6.50x average session volume. Relative to benchmarks, SGMO is outperforming the S&P 500 by +33.45%. 14-day RSI stands at 38.4, keeping momentum in a bearish regime.

Is SGMO stock a buy or sell right now?

Today's session carries a 68% catalyst conviction score on 6.50x relative volume (high participation). Our multi-factor model currently rates SGMO as HOLD. Review full valuation, quality, and timing signals on the SGMO Buy or Sell Decision Brief →

What is SGMO's intrinsic value and expected trading range?

At $0.18, SGMO's modeled 1-to-3 session range is $0.17 – $0.19, with a key inflection level at $0.22 (session resistance). Compare current price against multi-year cash flow projections in the SGMO Intrinsic Value & DCF Model → and Market Cycle Phase Tracker →

What do RSI and moving averages signal for SGMO?

RSI at 38.4 reflects soft below-midline momentum. SGMO trades at $0.18 relative to its 20-day SMA ($0.23) and 50-day SMA ($0.31), reflecting a bearish moving-average structure.

Tradestie Flagship Research & Market Hubs